SCHEMBL8180736

SCHEMBL8180736

COc1cccc(Oc2ccc(Cn3cc(CC(=O)O)c4ccccc43)cc2)c1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ PPARG P37231 3/20 0.53
▸ PPARD Q03181 3/20 0.53
▸ PPARA Q07869 3/20 0.53
▸ PLA2G2A P14555 2/20 0.50
▸ CHRM1 P11229 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ CHRNB2 P17787 2/20 0.48
▸ CHRNA7 P36544 2/20 0.48
▸ CHRNA4 P43681 2/20 0.48
▸ ICMT O60725 2/20 0.48
▸ MCL1 Q07820 3/20 0.48
▸ HTR6 P50406 1/20 0.47
▸ TUBB4A P04350 1/20 0.45
▸ TUBB P07437 1/20 0.45
▸ TUBA3C P0DPH7 1/20 0.45
▸ TUBA1B P68363 1/20 0.45
▸ TUBA4A P68366 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8178907 0.92 ALDH1A1 (0.56) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL13931405 0.90 ALDH1A1 (0.59) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8182990 0.86 PPARG (0.62) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8167192 0.86 PLA2G2A (0.60) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8178250 0.85 ALDH1A1 (0.56) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL7692305 0.85 CHRM1 (0.65) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8174618 0.85 LMNA (0.56) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8178901 0.84 ALDH1A1 (0.60) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL13931026 0.84 ALDH1A1 (0.65) ALDH1A1LMNAPPARGPPARDPPARA
SCHEMBL8175011 0.84 PPARD (0.65) ALDH1A1LMNAPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-02-19 — — US disclosed
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-02-19 — — US disclosed
WO-2008100867-A2 NOVEL INHIBITORS HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-08-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047246-A1 NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION EIF2AK2, HAVCR2, HCCS ALDH1A1 1836/4885LMNA 2969/4885PPARG 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback